A Timeline of COVID-19 Developments in 2020

Coronavirus infection 2019 (COVID-19) swept 2020. In this year, when the vaccine was closed, the pandemic was evolved and looked back on how it has evolved.

Updated January 1, 2021

At the end of the year, the SARS-COV-2 infected number of people in the United States exceeded 20 million, killing 346. 000 deaths. 83. 832. 334 people were infected and 1. 824. 590 deaths.

In some areas in the country, the number of infected people began to increase again after a few weeks after Thanksgiving. The same effect may be seen in January because the health authorities are seriously concerned about the extent of Christmas and winter vacation travel. According to the Transport Security Bureau, on Sunday before Christmas, the number of passengers (1. 3 million) has been screened since March 15.

The vaccine was distributed in the last month of the year, but the difficulty of distribution was revealed, and the United States did not reach the target of 20 million people by December 31.

This updates how the pandemic has progressed through 2020.

January 9th, WHO announces a mysterious pneumonia related to Coronovirus in China

At this time, the World Health Organization (WHO) is still suspicious of the roots of the Pandemic COVID-19, pointing out that the case of a series of pneumonia in Wuhan may be due to a new colon virus. 。 To date, 59 patients have occurred, and the prevention of travel is already at the forefront of concerns.

January 20-CDC announced that it will start screening Coronovirus at three airports in the United States.

The CDC will start screening at JFK International Airport, San Francisco International Airport, and Los Angeles International Airport in Thailand and Japan in 2019, with three new colonovirus infected people. These airports were chosen because of the highest passengers in the United States and the United States.

January 21-CDC confirmed the first Coronavirus infected in the United States.

After returning to Washington's state from Washington, he returned from Washu on January 15 and became the first in the United States to be found to be a new colon virus infected in 2019 by a night Polymerase Chain Reaction Test. The CDC immediately dispatched a team and supported the survey, including the possibility of tracking contacters.

January 21-Chinese scientists confirm the COVID-19 infection in humans

At this time, the 2019 novel coronavirus had killed four people and infected more than 200 in China before Dr. Zhong Nanshan finally confirmed that it was human-to-human. However, the WHO is still confident in the need to declare a public health emergency.

January 23 Wuhan is quarantined

In just two days, 13 more people died and 300 fell ill. China took the unprecedented step of not only sealing off Wuhan and its population of 11 million, but also Huanggang, 30 miles to the east, by placing entry restrictions on the city, preventing residents from leaving the city unless they had special permission. This means that up to 18 million people will be under strict lockdown.

January 31 Global Health Emergency

With the global death toll exceeding 200 and the number of infected exceeding 9, 800, the WHO finally declared a public health emergency for the sixth time. Human-to-human transmission is spreading rapidly, with cases confirmed in the United States, Germany, Japan, Vietnam, and Taiwan.

February 2: Global air travel restrictions

By 5 p. m. Sunday, anyone heading to the United States must have left China, and if they have been in Hubei province, they will be subject to a two-week quarantine. However, mainland visitors will have to undergo health screening upon returning home, and foreigners may even be denied entry. Similar aviation restrictions have also begun in Australia, Germany, Italy, New Zealand, and other countries.

February 3: United States declares public health emergency

The Trump administration declares a public health emergency due to the coronavirus outbreak. The announcement comes three days after a global health emergency was declared, with more than 9, 800 confirmed cases and more than 200 deaths worldwide.

February 10th - China's Covid-19 death toll surpasses SARS crisis

The death toll from Covid-19 surpasses that of Severe Acute Respiratory Syndrome (SARS) 17 years ago, with 908 deaths reported in China last month compared to 774 during the SARS crisis.

February 25th - CDC announces Covid-19 is heading for pandemic status

Regarding what Pandemic means, CDC's National Vaccination and Respiratory Disease Center Director Nancy Mesonier said that COVID-19 has now met two of the three necessary three elements. The worldwide spread is the third criterion and has not yet been satisfied.

March 6-21 passengers on California cruise ships are positive

A cruise ship carrying more than 3, 500 people from the California coast showed only 46 positive reactions of Cavid 19, and 19 crew members were infected with Cavid 19. The ship was detained on the sea without being allowed to be under ship in San Francisco while the inspection was conducted. Since the accident, 60 passengers have filed a cruise company and his parent company, Carnival, for ensuring serious negligence in ensuring passengers.

Month 11-Cobid 19 pandemic declaration

WHO's Secretary-General Tedoros Adano Gebrees declared that COVID-19 was a pandemic (global epidemic) in a briefing held in Geneva. He also expressed concern about "leveling of levels to worry about".

March 13-President Trump declares Cobid 19 the state emergency

President Donald Trump declares the new Coronavirus as a stat e-o f-th e-art situation and invests billions of federal government funds to expand infection.

March 13-The ban on travel from Europe is applied

The Trump administration has issued a ban on travel to no n-US citizens visiting 26 European countries within 14 days of entering the United States. Visitors from the United Kingdom and Ireland are not eligible.

March 17 The University of Minnesota started testing Hydroxyclrokin

The University of Minnesota has begun clinical trials to check whether hydroxyclrokin can prevent the onset of people exposed to COVID-19 or to reduce the severity of infection. The clinical trial is limited to those who have a high risk of exposure, aiming for 1500 people.

March 17-CMS, temporarily extended the use of telehels

CMS is expanding remote medical rules and acknowledging the use of COVID-19 pandemic as a means of protecting elderly patients from the possibility of infection. With this relaxation, med care can now be covered with remote care as in normal fac e-t o-face medical treatment.

On March 17, the government requests the American people to make immediate economic relief in Congress

President Trump is asking Congress to speed up the delivery of emergency relief checks to Americans as part of his stimulus package. The proposal comes just as the US reaches its 100th death from COVID-19.

19th March - California issues stay-at-home order

California becomes the first state to issue a stay-at-home order, forcing all residents to stay at home except when going to essential jobs or shopping for essentials. The order also requires the health system to prioritize serving the sickest people.

24th March - Clinical trials put on hold, innovation stalls

According to an interview, overwhelmed hospitals are admitting all non-essential patients, which means delaying the start of new clinical trials. According to a report from the Biosimilars Center, drugs that have just received FDA approval are unlikely to make it to market, and hospitals are struggling to secure enough protective staff.

March 25 - Reports suggest widespread layoffs could slow second wave

Mathematical models based on social exclusion measures applied in Wuhan, China, suggest that maintaining stricter measures for longer periods could flatten the Covid-19 curve.

March 26 - Senate passes bill

Provides $2 trillion in aid for hospitals, small businesses, and state and local governments, including the elimination of the Medicare buffer from May 1 to December 31, 2020.

March 27 - President Trump signs the Cares Act

The House of Representatives passes the Affordable Care Act, the largest economic recovery package in history, and President Trump signs it. The bipartisan bill provides direct payments and extends unemployment insurance to Americans.

March 30 - FDA approves the use of hydroxychloroquine.

FDA issues emergency use authorization (EUA) for "hydroxychloroquine phosphate and chloroquine phosphate formulations" to be donated to the Strategic National Stockpile and to hospitals for the treatment of CovID-19 patients. The EUA will be lifted on June 15, except for patients in clinical trials, after heart rhythm problems were reported in some patients.

31 March - CovID-19 can be transmitted through the eye

According to a report published in JAMA OPHTHALMOLOGY magazine, the virus, which causes COVID-19, is revealed that the patient may be infected from the eyes, even though it is rarely contained in tears. It is. Ajmc. com's highest number of readers in 2020, because of 38 patients in Hohoku Province, inconsistent with the assumptions of the major technical society.

April 8 COVID-19 cocktail problems

"What are you losing?" President Trump asks the covid-19 treatment of malaria therapy hydroxyclokin and related drug chlorokin. Using a common antibiotic aggienic substance, Ajislomycin, can prevent hospitalization and death. However, despite the fact that some patients have a risk in the heart, President Trump is promoting this combined therapy, so the American Heart Association, the American Heart Disease, and Cardiac Rhythm Society. A joint guidance warns that the drug is not used by anyone.

April 16 "Gateway Standard" appears as a method of resuming the economy

After President Trump temporarily shows the idea of ​​resuming the US economy in line with Easter Sunday (Sunday of the Resurrection Festival), the White House will return to work, churches, restaurants, etc. Announced a general guideline on whether it could be done. In this plan, the concept of "gateway standard" is outlined, and to state or the metropolitan area, a benchmark for reducing COVID-19 infected or dead before going to the next step toward resuming. We are asking to achieve it.

April 28-Young and poor people avoid care for COVID-19 symptoms

As the pandemic was prolonged, the word "deferred care (postponed treatment)" became popular in the medical community. According to Gallup's opinion polls, this phenomenon has a dark aspect. One in seven Americans replied that even if the typical COVID-19 symptoms, fever or dry cough, do not receive treatment. What is the reason? I am concerned about the cost. The most likely to avoid treatment for symptoms is those under the age of 30 and their annual income of $ 40. 000 or less. 26. 5 million Americans have submitted unemployment notifications since mi d-March and by the end of April.

April 29-Nih clinical trials Remdicville is promising early

In non-peer test data, the US National Institute of Health (NIH) showed that Remdecville made by Gilado Sienshis was better than Plasbo in the treatment of COVID-19. For patients with lung-lung lesions in the progressive COVID-19, the recovery was 31 % earlier, about four days.

May 1st Remdeceville, EUA

Shortly after the release of the clinical trial data, the FDA granted EUA to Remdesivir. Preliminary data from the NIH clinical trial found that the treatment promoted recovery in patients with advanced COVID-19 infection and lung involvement.

May 9 - Saliva-based diagnostic test approved for home use

The FDA has expanded authorization for saliva-based tests to detect COVID-19 infection, and EUA was granted to Rutgers Clinical Genomics Laboratory. The test will allow people who cannot travel to a collection center to be tested, such as homebound patients who are at high risk for infection due to illness, quarantine, age or comorbidities.

May 12 - Fauci testifies death toll likely underestimated

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, testified before the U. S. Senate, saying the 80, 000 U. S. death toll is likely underestimated. He warned against relaxing social distancing and said he was "cautiously optimistic" that a vaccine would work and that a cure would be achieved within a year or two.

21 May - US and AstraZeneca sign vaccine deal

The Trump Administration and AstraZeneca announce a partnership to accelerate development of a vaccine for COVID-19, called AZD1222. According to HHS, the first doses could be available as early as October 2020. Phase 3 clinical trials will be conducted this summer.

May 28 - The number of COVID-19 deaths in the US surpasses 100, 000.

The CDC says the death toll is "a sorrowful moment and a horrific reminder of the terrible toll of this unprecedented pandemic." The CDC urges Americans to continue following local and state guidelines on prevention strategies, including social distancing, good hand hygiene, and wearing masks in public.

June 4 - Lancet, NEJM retract COVID-19 studies on hydroxychloroquine

On the same day, the New England Journal of Medicine and the Lancet retracted two studies on the use of hydroxychloroquine in COVID-19. The two studies used a private database of medical records created by a little-known company called Surgisphere. The retractions highlight the difficulty of publishing important research on COVID-19 while ensuring accuracy.

June 10 - U. S. COVID-19 cases reach 2 million

The number of confirmed cases of COVID-19 in the United States has reached 2 million, and new infections continue to rise in 20 states. Cases are beginning to rise as states relax social distancing restrictions.

June 16-HHS announced that some vaccination will be free of charge

COVID-19 A-TED States Warp Speed, a project that quickly develops and deploys vaccines, explains that it will be provided free of charge for elderly patients or vulnerable people who can not afford other vaccines.

June 18 Who is the end of the Hydroxyclrokin test?

It was announced that who will cancel the Hydroxyclrokin test as a COVID-19 treatment. According to the data in the solidarity test, the drug did not reduce the mortality rate. According to the WHO, patients who have been administered in hydroxyclokin will complete or cancel the administration based on the discretion of the instructor.

June 20 NIH canceled Hydroxyclrokin's clinical trial

NIH has announced that it will cancel clinical trials to verify the safety and effectiveness of hydroxyclrokin as a covid-19 treatment. It was shown that hydroxyclrokin was harmless but ineffective.

Research results that 80 % of infected people were not found in June 22-March

According to studies published in Scientific Translation of Medicine, up to 80 % of Americans, which were examined in March for symptoms like influenza, were actually infected with viruses that cause COVID-19. According to this study, if one-third of these patients had a COVID-19 test, it could be 8. 7 million infections.

June 26-The White House Coronavirus Countermeasures Committee deals with the increase in infected people in the southern part

The White House Coronavirus Countermeasures Committee has announced the latest information for the first time in two months. The focus of the discussion is the increase in the number of cases and the increase in positive reaction rates in several states. Texas and Florida have decided to cancel the retesting as the number of patients has increased.

June 29-Gilado sets the price of Remdicvill to $ 3120

Gilado Sienshis has set the price of Remdecville, which can shorten the hospitalization period of Cobid-19 patients, to $ 520. If the treatment course is six vials, the typical treatment course per patient covered with private insurance will be $ 3, 120. Critics for the price setting pointed out that the COVID-19 Remdicivir clinical trials are taxes through the National Allergies and Institute of Infectious Diseases.

June 30-Fauci warns that a new patient of Cobid-19 will reach 100, 000 a day.

Fauti, who attended the Senate Welfare, Education, Labor, and Pension Committee, is currently in the United States with around 40, 000 new people per day, but in light of the current trajectory, 1. He warns that the number of new infections on the day may reach 100, 000.

Month 2-Each state withdraws plan

Several states, including California and Indiana, will postpone or withdraw for economic resumption while the United States records 50, 000 new patients in Cobid 19. New Mexico will also extend public health emergency orders until July 15 and impose a fine of $ 100 to those who have not obliged the use of masks.

July 6-The scientists are asking who will review their guidance because of air infection.

Hundreds of scientists have called on the WHO to fix the Cobid 19 recommendations to further reflect the possibilities of Cobid 19 air infection. To date, the WHO has announced that the COVID-19 is mainly infected with the cough, sneezing of infected people, and small droplets coming out of the nose and mouth during conversations.

July 7-CMS plans to increase payment to home dialysis equipment

CMS proposes rules for the purpose of preventing patients from receiving treatment at the dialysis center. Transitional payments for new and innovative devices and consumables will increase access to home dialysis equipment and improve the accessibility of Medicare recipients.

July 7 The United States has exceeded 3 million infected people and begins to withdraw

On the same day, the United States reported 3 million COVID-19 infected people, reported on the world's trend, and began to withdraw from the WHO. The decision will not come into effect until 2021 and may be withdrawn by the next President Joe Biden.

September-Where did Cavid 19 announcing the possibility of air infection?

The new Coronavirus has announced that it could be infected. The updated scientific outline pointed out that viruses could be infected even in crowded indoor environments, emphasizing that asymptomatic people could infect.

On July 14, COVID-19 increased the number of health insurance in the rapid increase in health insurance.

According to the Family's USA analysis, as of May 2020, the state of the highest insurer except for the elderly is the State, Texas, Oklahoma, Mississippi, North Carolina, South Carolina, and Georgia, and Georgia. It is. As of July 12, these states have the largest COVID-19 new infection per 100, 000 residents.

July 14-Moderna's initial data shows the effectiveness of the candidate vaccine

According to the data of Moderna Inc.'s Covid-19 vaccine 1/2 clinical trials, an immune reaction was found in all 15 volunteers in all three groups. The company first entered a large human clinical trial. The side effects of this candidate vaccine, which is administered twice at 28 days, includes the pain of the injection site and the chills.

15 July New Hospital Data Report concerns about protocol

According to the notification, all hospitals must bypass the CDC and send information about COVID-19 to the central database managed by HHS Protect. Until now, data has been sent to the CDC's National Health Security Network website. In response to this change, there has been a question about the future transparency and politics of COVID-19 data.

July 16-The United States reports a new record of the number of people infected in COVID-19 in the United States

In the United States, the number of COVID-19 infected people per day was 75. 600, updating the previous week's record. At this point, the number of infected people per day has been updated 11 in the past month. Texas, Hawaii, and Montana have reported new records per day in 10 states.

July 20-The delay in diagnosis by COVID-19 may increase cancer-related deaths

In the next few years, thousands of more cancer deaths, which should have been prevented from daily diagnostic care, which were delayed by the COVID-19 epidemic, could be witnessed. Specifically, the introduction and screening of breast cancer, colorectal cancer, esophageal cancer, lung cancer, and delays in screening are two studies published in Lancet Oncology, almost 10 % in England (N = 3291-). 3621) It was suggested that it could lead to many deaths. 5 years

July 2 1-Astrazeneka and Kansino Bio Loggus vaccine show promising results

Two experimental vaccines, astrazena and Cansino Biologics, have shown promising results for COVID-19. According to Astrazenka's AZD1222 COV001 1/2 phase test, the vaccine was resistant and all the evaluated participants gave a powerful immune response to the virus. In the second phase of the Cansino, 95 % of patients were recognized for 95 % of patients on the 28th day after vaccination, and significant neutral antibodies were obtained.

July 22-HHS and the Ministry of Defense announced a vaccine sales agreement between Pfizer and Bion Tech

The HS and the Defense Pentagon (DOD) will partner with Biotechnology, Bion Tech, and will deliver 100 million COVID-19 vaccine BNT162 in December. This contract may expand to 600 million times if the vaccine has obtained FDA or EUA, and even in that case, as a result of the third phase clinical trial, the safety and effectiveness of the vaccine are confirmed. Limited to.

7/2 3-COVI D-19 The antibody level declines in 3 months after infection

According to a research report published in the New English Journal of Medicine magazine, the antibody level for COVID-19, a virus of COVID-19, has dropped dramatically three months after the infection. Researchers have pointed out that the resistance to antibodies will be exhausted within one year, but experts have pointed out that the possibility of r e-infection with the virus is extremely low.

23 Jul y-The antibody cocktail can treat and prevent COVI D-19

We have developed an antibody cocktail that acts antibodies to different parts that form a "crown" of a virus called "spike" in SARS-COV-2. Scientists have discovered that antibodies are divided into two different groups and targeting different areas of virus spikes. Therefore, the battle with COVID-19 may be fighting on separate fronts, such as the battle against HIV and a certain kind of cancer.

Month 27t h-Moderna vaccine started the third phase exam and received $ 472 million from the Trump administration

At the beginning of the first three-phase clinical trial to test a vaccine candidate for COVID-19, the Moderna has expanded the Trump administration to increase $ 472 million and expand the test to 30, 000 participants in the United States. We announced what we did. As a result, the total investment by the Advanced Medical Research and Development Bureau reaches $ 9505 million.

July 27 Senate submits the Heals method

The Republican Party has submitted a bill called "Health, Finance Support, Responsibility Protection, School (HEALS) Law", and tries to return workers to workplaces during pandemic, checking for economic stimulation measures, funding for small and mediu m-sized enterprises. Liability protection is specified.

July 29-Fda recognizes the EUA for quick antibody tests in True Vian

The FDA was granted EUA because Truvian Sciences's COVID-19 IGM/IgG quick antibody testing exceeded the EUA requirements, such as 98, 44 % of sensitivity and 98, 9 % specificity. The announcement was due to the demanding of the FDA on May 5 to strengthen monitoring against antibody tests and met the same criteria as other molecular tests.

August 3-A new pandemic phase in the United States. Pay Sanofi and Glaxo Smith Cline of $ 2 billion.

According to Deborah Birks Medicine, Coronovirus Countermeasures, the United States has entered a new pandemic stage. Berks commented on the United States in response to the $ 2. 1 billion agreement with Glaxo Smith Cline and Sanofi Pastor with a $ 2. 1 billion agreement aimed at developing, manufacturing, and expanding Cobid-19 vaccines. 。

August 4-Local hot spots face the lack of beds in the intensive care room

Nearly five months have passed since the pandemic has occurred in the United States, but 49 % of the lo w-income groups do not have an intensive care bed, but 3 % for the wealthy. The hospital is now forced to transfer sick patients to these wealthy local care facilities, and the southwest and western part are facing a particularly severe bed shortage.

August 7 Discussion on the second relief measures

However, despite the highest number of unemployment insurance, the White House and the Democratic Party have discussed the possibility of remedies. President Trump has argued that if he does not reach the agreement, he will issue a presidential decree.

On the 11th, the Trump administration, Modena, < SPAN> The Republican Party has submitted a bill called "Health, Financial Support, Responsibility Protection, School (HEALS) Law", and financial support for small and mediu m-sized enterprises, It stipulates liability for companies that try to return workers to the workplace during pandemic.

July 29-Fda recognizes the EUA for quick antibody tests in True Vian

The FDA was granted EUA because Truvian Sciences's COVID-19 IGM/IgG quick antibody testing exceeded the EUA requirements, such as 98, 44 % of sensitivity and 98, 9 % specificity. The announcement was due to the demanding of the FDA on May 5 to strengthen monitoring against antibody tests and met the same criteria as other molecular tests.

August 3-A new pandemic phase in the United States. Pay Sanofi and Glaxo Smith Cline of $ 2 billion.

According to Deborah Birks Medicine, Coronovirus Countermeasures, the United States has entered a new pandemic stage. Berks commented on the United States in response to the $ 2. 1 billion agreement with Glaxo Smith Cline and Sanofi Pastor with a $ 2. 1 billion agreement aimed at developing, manufacturing, and expanding Cobid-19 vaccines. 。

August 4-Local hot spots face the lack of beds in the intensive care room

Nearly five months have passed since the pandemic has occurred in the United States, but 49 % of the lo w-income groups do not have an intensive care bed, but 3 % for the wealthy. The hospital is now forced to transfer sick patients to these wealthy local care facilities, and the southwest and western part are facing a particularly severe bed shortage.

August 7 Discussion on the second relief measures

However, despite the highest number of unemployment insurance, the White House and the Democratic Party have discussed the possibility of remedies. President Trump has argued that if he does not reach the agreement, he will issue a presidential decree.

The Trump administration, Modena, and the Republican Party with the Modena, have submitted a bill called "health, financial support, liability protection, school (HEALS) law," and work at the time of pandemics, pandemic, a check for economic stimuli measures. It stipulates liability for companies trying to return to work.

July 29-Fda recognizes the EUA for quick antibody tests in True Vian

The FDA was granted EUA because Truvian Sciences's COVID-19 IGM/IgG quick antibody testing exceeded the EUA requirements, such as 98, 44 % of sensitivity and 98, 9 % specificity. The announcement was due to the demanding of the FDA on May 5 to strengthen monitoring against antibody tests and met the same criteria as other molecular tests.

August 3-A new pandemic phase in the United States. Pay Sanofi and Glaxo Smith Cline of $ 2 billion.

According to Deborah Birks Medicine, Coronovirus Countermeasures, the United States has entered a new pandemic stage. Berks commented on the United States in response to the $ 2. 1 billion agreement with Glaxo Smith Cline and Sanofi Pastor with a $ 2. 1 billion agreement aimed at developing, manufacturing, and expanding Cobid-19 vaccines. 。

August 4-Local hot spots face the lack of beds in the intensive care room

Nearly five months have passed since the pandemic has occurred in the United States, but 49 % of the lo w-income groups do not have an intensive care bed, but 3 % for the wealthy. The hospital is now forced to transfer sick patients to these wealthy local care facilities, and the southwest and western part are facing a particularly severe bed shortage.

August 7 Discussion on the second relief measures

However, despite the highest number of unemployment insurance, the White House and the Democratic Party have discussed the possibility of remedies. President Trump has argued that if he does not reach the agreement, he will issue a presidential decree.

On the 11th of the month, the Trump administration agreed with Modena

While we are still waiting for the final numbers, the Trump Administration has reportedly agreed to pay Moderna $1. 5 billion (average price of $15 per dose) for 100 million doses of its vaccine candidate, mRNA-1273. However, the vaccine is still being investigated in the Phase 3 COVE trial, which Moderna is conducting in collaboration with the National Institute of Allergy and Infectious Diseases and the Biomedical Advanced Research and Development Organization.

August 12 - Severe obesity increases risk of COVID-19 death

Kaiser Permanente researchers published a study showing that patients with a body mass index (BMI) of 40-44 kg/m2 have more than twice the risk of death from COVID-19 compared to patients with a BMI of 18. 5-24 mg/m2. The rich and comprehensive patient data allowed the research team to isolate the effects of obesity compared to those arising from more than 20 comorbidities, healthcare utilization, population density, and more. The crux of the finding is that excess fat worsens respiratory damage from COVID-19.

August 13 - Biden calls for 3-month mask mandate

While still running for president, Joe Biden has asked all governors until November to make sure their citizens wear masks whenever they go out in public, claiming that if elected, he will enforce this habit. 165 cases have been reported so far. It is estimated that 1, 000 people have died from COVID-19, and that the measure will save 40. 000 lives in the coming months. At this time, masking mandates still vary widely by state and district.

August 15 - FDA approves saliva test

The federal agency issues an EUA for Saliba Direct, a less invasive test than the current standard nasal swab, developed by researchers at the Yale School of Public Health. With reduced waiting times that do not affect the sensitivity of the test, laboratories can test 90 samples collected in a sterile container in less than three hours. The test is also inexpensive and produces results similar to nasal swabs.

August 17 - COVID-19 is now the third leading cause of death in the United States.

In just four days, COVID-19-related deaths increased 3. 2% to 170. The number of deaths has exceeded 1, 000 a day, and the number of cases nationwide has exceeded 5. 4 million. Trials are running an average of 68 cases a day. This is despite the fact that the odds of dying are eight times higher in the United States than in Europe.

August 23rd: FDA approves use of plasma

The FDA has filed a new drug application for recovered patient plasma as a treatment for Covid-19. The treatment remains controversial, with a lack of data on its effectiveness leading to skepticism from experts that all patient populations would benefit from it. Meanwhile, White House Press Secretary Kayleigh McEnany has claimed the treatment is groundbreaking.

August 24th: Remdesivir's clinical usefulness called into question

Antiviral drug remdesivir has had little effect on patients hospitalized with COVID-19, a global multi-center study has found. According to the findings published in JAMA, there was no significant difference in the duration of supplemental oxygen or length of hospital stay between the intervention group given remdesivir and the control group given standard care.

August 25th - CDC changes testing guidance, but later retracts

The CDC quietly changes its guidance on who should be tested for COVID-19, saying that people who have been exposed, even if asymptomatic, do not need to be tested. The change was retracted after it became clear that the decision bypassed the CDC's normal scientific review process and was made without internal review.

August 26th - FDA grants EUA to Abbott's accelerated test

A portable rapid Covid-19 test that can provide results in under 15 minutes has been authorized by the FDA under an EUA. The test is intended for use in workplaces, schools, and more.

August 28th - The first known case of Covid-19 review in the United States is reported.

A 25-year-old man living in Nevada reportedly contracted Covid-19 again in late May after recovering from a mild case in April. This is the first reported case of recurrence in the United States. The second case was severe enough to require hospitalization and oxygen support. The full case series will be published in the Lancet Infectious Disease Journal in October.

September 1 - US rejects global Covid-19 vaccine effort

The US announced it would not join the WHO's Covax-19 vaccine development, manufacturing and distribution initiative. Covax, which includes 172 countries, was created to distribute any completed vaccine equally to poor and developing countries.

September 3 - Steroids reduce mortality in severe cases. Sanofi and GSK begin human vaccine clinical trials.

Three studies have reported that inexpensive steroids are the most effective treatments so far to severe COVID-19. These studies have shown that the use of systemic adrenocortic steroids reduces the risk of death of people in COVID-19 to one-third, compared to normal treatment and placebo.

In addition, Sanofi and Glaxo Smith Cline (GSK) have started clinical trials on protei n-based vaccines. The COVID-19 vaccine uses the same protein-based technology as Sanofi's influenza vaccine, and uses an immune-enhanced agent (booster) developed by GSK.

September 3-Biological ethics gives opinions about fair vaccine distribution

19 biological ethics outlaws measures to fairly distribute the limited supply of Cobid-19 vaccines. This plan, called a fair-priority model, takes into account three types of harm caused by the value of COVID-19, and three things that must be protected when considering the shortage of vaccines.

September 8-Astraseneca canceled the third phase vaccine test

Astrazenka's COVID-19 vaccine third phase clinical trial was canceled for safety data reviews due to unknown side effects in one patient. The patient belonged to the British test group. At that time, the nature of the side effects was unknown, but the company said that the participants are expected to recover. According to Astrazenka, this hold has begun as a "daily measure."

September 14-US airport stops screening of foreign travelers

The government announced that it will cancel the screening at some airports from January. In March, immigration flights from hig h-risk countries, including most of China, Iran, and Europe, were via 15 designated airports, but since September 14, there are no detours of stools, all passengers. Screening is stopped. As part of the screening, passengers were checked for body temperature before passport control and customs, and received basic health checks on typical COVID-19 symptoms.

September 14-Piazer, Bion Tech Expland 3 phase 3rd exam < Span> reports that inexpensive steroids are the most effective treatments so far for severe COVID-19. I am. These studies have shown that the use of systemic adrenocortic steroids reduces the risk of death of people in COVID-19 to one-third, compared to normal treatment and placebo.

In addition, Sanofi and Glaxo Smith Cline (GSK) have started clinical trials on protei n-based vaccines. The COVID-19 vaccine uses the same protein-based technology as Sanofi's influenza vaccine, and uses an immune-enhanced agent (booster) developed by GSK.

September 3-Biological ethics gives opinions about fair vaccine distribution

19 biological ethics outlaws measures to fairly distribute the limited supply of Cobid-19 vaccines. This plan, called a fair-priority model, takes into account three types of harm caused by the value of COVID-19, and three things that must be protected when considering the shortage of vaccines.

September 8-Astraseneca canceled the third phase vaccine test

Astrazenka's COVID-19 vaccine third phase clinical trial was canceled for safety data reviews due to unknown side effects in one patient. The patient belonged to the British test group. At that time, the nature of the side effects was unknown, but the company said that the participants are expected to recover. According to Astrazenka, this hold has begun as a "daily measure."

September 14-US airport stops screening of foreign travelers

The government announced that it will cancel the screening at some airports from January. In March, immigration flights from hig h-risk countries, including most of China, Iran, and Europe, were via 15 designated airports, but since September 14, there are no detours of stools, all passengers. Screening is stopped. As part of the screening, passengers were checked for body temperature before passport control and customs, and received basic health checks on typical COVID-19 symptoms.

September 14-Pfizer-Bion Tech Expland 3-phase 3 studies reported that inexpensive steroids are the most effective treatments so far to the severe COVID-19. These studies have shown that the use of systemic adrenocortic steroids reduces the risk of death of people in COVID-19 to one-third, compared to normal treatment and placebo.

In addition, Sanofi and Glaxo Smith Cline (GSK) have started clinical trials on protei n-based vaccines. The COVID-19 vaccine uses the same protein-based technology as Sanofi's influenza vaccine, and uses an immune-enhanced agent (booster) developed by GSK.

September 3-Biological ethics gives opinions about fair vaccine distribution

19 biological ethics outlaws measures to fairly distribute the limited supply of Cobid-19 vaccines. This plan, called a fair-priority model, takes into account three types of harm caused by the value of COVID-19, and three things that must be protected when considering the shortage of vaccines.

September 8-Astraseneca canceled the third phase vaccine test

Astrazenka's COVID-19 vaccine third phase clinical trial was canceled for safety data reviews due to unknown side effects in one patient. The patient belonged to the British test group. At that time, the nature of the side effects was unknown, but the company said that the participants are expected to recover. According to Astrazenka, this hold has begun as a "daily measure."

September 14-US airport stops screening of foreign travelers

The government announced that it will cancel the screening at some airports from January. In March, immigration flights from hig h-risk countries, including most of China, Iran, and Europe, were via 15 designated airports, but since September 14, there are no detours of stools, all passengers. Screening is stopped. As part of the screening, passengers were checked for body temperature before passport control and customs, and received basic health checks on typical COVID-19 symptoms.

September 14-Pfizer, Bion Tech Extrand 3rd Phase Examination

Pfizer and BioNTech, which initially aimed to recruit 30, 000 people, announced that they would expand their Phase 3 trial of their Covid-19 vaccine by 50%, to 44, 000. 000. The goal of the trial expansion is to increase data on safety and efficacy and to encourage more diverse populations, including adolescents as young as 16 and people with HIV, Hepatitis C and Hepatitis B. The Pfizer/BioNTech vaccine is administered in two doses. It lasts for three weeks, but the vaccine must be stored at minus 70 degrees Celsius (minus 94 degrees Fahrenheit), which could make it difficult to distribute.

September 14 - NIH begins investigation into AstraZeneca trial halt

After AstraZeneca halted its Phase 3 trial, the NIH announced that it would begin an investigation into side effects before the FDA decides whether to continue the trial. Participants sustained spinal cord injuries, and it remains unclear what caused the injuries.

September 15th - CDC reports on spread of Covid-19 in restaurants

A study published in the weekly journal Morbidity and Mortality Report found that people who recently tested positive for Covid-19 were 2. 4 times more likely to have eaten out. In the study, restaurant seating included patios, outdoors, and indoors. Participants who had been in bars and cafes were nearly four times more likely. The majority of participants (71%) claimed to have worn a mask in the two weeks prior to their diagnosis.

September 16th Trump Administration Announces Vaccine Distribution Plan

The plan devised by HHS and the Department of Defense aims to provide a free Covid-19 vaccine to all Americans when it becomes available in January 2021. If a vaccine is approved, 66 million kits of supplies needed to administer the vaccine will also be distributed. The plan does not include any decision on who will be vaccinated first.

September 17 - Covid-19 cases rise in Europe

Covid-19 cases are rising rapidly in Europe, outpacing the previous peak in March. More than half of European countries reported increases of 10% or more in the first half of September.

September 21 - CDC reverses guidance that Covid-19 is airborne

The CDC removed guidance from the website published three days ago that COVID-19 infection was air infection. According to the CDC, the document was incorrectly posted, and the guidance was "version of the change."

September 21-Johnson End Johnson started the third phase vaccine test

Johnson End Johnson has announced that it has launched a large third phase clinical trial for COVID-19 vaccine candidates. This vaccine does not need to be stored frozen and may only need one administration instead of two doses. This clinical trial is scheduled to be conducted for 60. 000 participants, the largest third phase test in all vaccines currently under the test.

September 23-A new Cobid 19 with more infectious power is discovered

A study conducted at the Houston Methodist Hospital found that most of the recent patient samples have found 19 more infectious Cobid. Researchers analyze the first steps of pandemic and the recent infection wave samples, and almost all of the stocks in the latest stage have a mutation that enables viruses to bind and infect more to more cells. I found that.

September 25-COVID-19 infected people increase in each state

In September, COVID-19 infected people increased dramatically in the Midwest states, an increase of 166 % in South Dakota alone, and in the other 10 states, the number of infected people per day recorded a record high. The annual Star Jis, motorcycle racing, schools, universities, and workers' celebrations are listed as related.

September 28-The number of deaths in the world by COVID-19 exceeded 1 million

According to the New York Times, the number of deaths related to COVID-19 exceeded 1 million worldwide, exceeding the total number of deaths due to HIV, dysentery, malaria, influenza, cholera, and measles.

September 29-HHS distributes 100 million quick inspections to each state

HHS has announced plans to distribute the Rapid Cobid-19 tests developed by Abbott to 100 million people this year. Quick tests are cheaper and quicker than inspection in the laboratory, and can be achieved in about 15 minutes. This plan is to support school resuming from kindergarten to high school.

September 29-Ligeneron announces good results of monoclonal antibody treatment

Regeneron announced results from an ongoing Phase 1/2/3 trial showing that Regn-Cov2, a proposed monoclonal antibody treatment for Covid-19, is associated with faster recovery, lower viral load, and fewer doctor visits. Regn-Cov2 is a mixture of two monoclonal antibodies (Regn10933 and Regn10987).

October 2 - President Trump, First Lady Test Positive for Covid-19? President Trump Hospitalized

President Trump announced that he and First Lady Melania Trump had tested positive for Covid-19. After experiencing mild symptoms of the disease, President Trump was transported to Walter Reed National Military Center "as a precaution," Press Secretary Kayleigh McEnany said in a statement.

October 5 - Trump Released from Hospital, Treatment Continuing

Three days later, President Trump was released from the hospital and transferred to the White House, where he will continue to be monitored while receiving treatment for Covid-19. According to White House physician Sean Conley, the president's fever has subsided and his oxygen levels are normal. During his hospital stay, President Trump's treatment consists of the experimental antibody cocktail Regeneron, remdesivir, and dexamethasone.

October 8 - NEJM Criticizes Trump's COVID-19 Response 39 States See Case Surge

In an editorial published by the New England Journal of Medicine (NEJM), 34 editors slammed the Trump Administration's response to the COVID-19 pandemic, saying leaders "turned a crisis into a tragedy."

In addition, 39 states reported an increase in COVID-19 cases. Nine states broke their seven-day case records, and Wisconsin and Hawaii recorded their highest seven-day death counts ever.

October 8th - More Americans trust Biden to lead our health care system

A Gallup West Health poll released today (but conducted before President Trump's Covid-19 diagnosis) found that more Americans trust Biden to lead the U. S. health care system through the pandemic. The poll found Biden had the support of 52% of voters on the issue, compared with 39% for Trump and the rest undecided. The results leave room for Trump to narrow Biden's lead in the national polls.

October 8th - White House Covid-19 outbreak grows to 34

According to the Washington Post, there are 34 COVID-19 infected COVID-19, including the Rose Garden ceremony in the Amy Connie Barrett Supreme Court as of today. CDC experts are supporting contact tracking.

October 9 The United States has a contract with Astrazenka

The Trump administration has signed a $ 486 billion contract with Astrazeneca to develop COVID-19 antibody therapy. In cooperation with the company, HHS and State Affairs will develop late development and larg e-scale production of cocktails, AZD7442. Two types of monoclonal antibodies may be used to treat and prevent this disease.

October 12 Johnson End Johnson canceled the vaccine exam

Johnson End Johnson has suspended the vaccine test due to an unknown patient in the Covid-19 vaccine's third phase ENSEMBLE test. The company stated that at that time, the suspension of recruitment was not unusual, but it means that clinical trials are being conducted in a safe way. The company has since continued research on one of the most unique vaccine candidates. The company has also announced Ensemble 2, which tests the tw o-time vaccine.

October 15-US case. Research related to blood type and COVID-19 risk

In the United States, 60. 000 newly infected COVID-19 infected people have been numbers since early August. The number of cases is increasing nationwide, exceeding the number of cases reported in mi d-September in 44 states. Furthermore, in rural states, the number of patients is further increased than the first epidemic in the spring.

Two studies published in the Blood ADVANCE magazine suggested that the risk of COVID-19 infections and the risk of complications threatening life by viruses is related to blood type. Researchers say that the result does not suggest that any blood type defends or vulnerable to the virus.

October 19 Over 40 million infected people around the world

According to data released by Johns Hopkins, COVID-19 infected people have exceeded 40 million worldwide. To date, more than 1. 1 million people have died in the world, of which 220, 000 have died in the United States.

October 22-Fda approves Remdecville as the first treatment of COVID-19

Gilado's Remdecville was first approved by the FDA as a COVID-19 treatment. Three unreasonable tests showed that the hospitalization period would be shortened and the possibility of inhaling oxygen was required. However, any clinical trials have not found a decrease in the risk of death, and a study supported by the WHO states that the drug is "almost effective" for inpatients. The FDA did not quote the WHO test in Remde Desible's risk benefit evaluation, and supported the approval, stating that NIH's supported tests were more appropriate for recovery time evaluation than the WHO test.

October 23-Astrazeneka and Johnson End Johnson announced the resumption of COVID-19 vaccine exams

Astrazenka and Johnson End Johnson have announced plans to resume clinical trials for each COVID-19 vaccine candidate, which were canceled due to safety concerns. Johnson End Johnson's clinical trials were canceled on October 11, and the Astra Seneca clinical trials had one patient had neurological symptoms before being canceled on September 6. The Independent Surveillance Committee has ruled that the latest vaccine candidates can continue safely.

October 28-CMS announces the insurance coverage of vaccine and treatment insurance

CMS will set new rules for insurance coverage, and increase the amount paid to the hospital for COVID-19 treatment. President Trump and Congress had signed a bill for free COVID-19 vaccine, but new rules were needed to integrate this policy into various payment requirements for public insurance and private insurance. The new rules exempt additional payments and exemptions for the elderly vaccines for the elderly who are enrolled in Medicare.

November 4-The United States, unprecedented in one day.

In the United States, 100, 000 new COVID-19 infected people were reported in a day, reaching a serious milestone for the first time. Due to the increase in unprecedented infected people, medical facilities are lacking in N95 face masks despite the increase in production, and workers continue to distribute masks and reuse endlessly.

On November 5th, a research result < Span> Gilian's Remdeceville, which predicts the difficulty of nationwide immunity to COVID-19, was first approved by the FDA as a COVID-19 treatment. Three unreasonable tests showed that the hospitalization period would be shortened and the possibility of inhaling oxygen was required. However, any clinical trials have not found a decrease in the risk of death, and a study supported by the WHO states that the drug is "almost effective" for inpatients. The FDA did not quote the WHO test in Remde Desible's risk benefit evaluation, and supported the approval, stating that NIH's supported tests were more appropriate for recovery time evaluation than the WHO test.

October 23-Astrazeneka and Johnson End Johnson announced the resumption of COVID-19 vaccine exams

Astrazenka and Johnson End Johnson have announced plans to resume clinical trials for each COVID-19 vaccine candidate, which were canceled due to safety concerns. Johnson End Johnson's clinical trials were canceled on October 11, and the Astra Seneca clinical trials had one patient had neurological symptoms before being canceled on September 6. The Independent Surveillance Committee has ruled that the latest vaccine candidates can continue safely.

October 28-CMS announces the insurance coverage of vaccine and treatment insurance

CMS will set new rules for insurance coverage, and increase the amount paid to the hospital for COVID-19 treatment. President Trump and Congress had signed a bill for free COVID-19 vaccine, but new rules were needed to integrate this policy into various payment requirements for public insurance and private insurance. The new rules exempt additional payments and exemptions for the elderly vaccines for the elderly who are enrolled in Medicare.

November 4-The United States, unprecedented in one day.

In the United States, 100, 000 new COVID-19 infected people were reported in a day, reaching a serious milestone for the first time. Due to the increase in unprecedented infected people, medical facilities are lacking in N95 face masks despite the increase in production, and workers continue to distribute masks and reuse endlessly.

On November 5, Research Predicted the difficulty of immunity to COVID-19, Gilado's Remdecville was first approved by the FDA as a COVID-19 treatment. Three unreasonable tests showed that the hospitalization period would be shortened and the possibility of inhaling oxygen was required. However, any clinical trials have not found a decrease in the risk of death, and a study supported by the WHO states that the drug is "almost effective" for inpatients. The FDA did not quote the WHO test in Remde Desible's risk benefit evaluation, and supported the approval, stating that NIH's supported tests were more appropriate for recovery time evaluation than the WHO test.